DePuy Synthes introduced SENTIO MMG, a digital mechanomyography platform designed to assess nerve status and identify and avoid peripheral nerves during spine surgery.
Sentio’s platform uses adhesive smart-sensors that are applied to the patient’s skin and provide the surgeon with real-time feedback on nerve location. The technology has a minimal footprint in the O.R. and obviates the need for a neuromonitoring specialist in the room. Johnson & Johnson acquired the technology in mid-2017.
Source: DePuy Synthes
DePuy Synthes introduced SENTIO MMG, a digital mechanomyography platform designed to assess nerve status and identify and avoid peripheral nerves during spine surgery.
Sentio’s platform uses adhesive smart-sensors that are applied to the patient's skin and provide the surgeon with real-time feedback on nerve location. The technology has a...
DePuy Synthes introduced SENTIO MMG, a digital mechanomyography platform designed to assess nerve status and identify and avoid peripheral nerves during spine surgery.
Sentio’s platform uses adhesive smart-sensors that are applied to the patient’s skin and provide the surgeon with real-time feedback on nerve location. The technology has a minimal footprint in the O.R. and obviates the need for a neuromonitoring specialist in the room. Johnson & Johnson acquired the technology in mid-2017.
Source: DePuy Synthes
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.